Product Code: ETC103847 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Indonesia tetracyclin market is one of the key markets in Southeast Asia for this important antibiotic. Tetracycline has been used as a broad-spectrum antibiotic since its discovery in 1948 and is still widely used to treat bacterial infections today. It is an inexpensive, low-tech drug that can be easily administered intravenously or orally and requires no special storage conditions. The Indonesia market for tetracyclines consists mainly of generic products from domestic manufacturers such as Kimia Farma, Kalbe Farma, Tempo Scan Pacific and Sanbe Farma.
The demand for tetracyclines in Indonesia has been growing steadily over the past decade due to rising infectious diseases rates. In particular, increased prevalence of multi-drug resistant bacteria has led to an increase in prescriptions for antibiotics across all healthcare sectors including hospitals, clinics and pharmacies throughout Indonesia. As a result of this growth trend, several new generics companies have entered the Indonesia market offering cheaper versions of tetracyclines which are lower quality than those produced by established multinational companies such as Pfizer or Merck & Co but still meet FDA standards. In addition , the government?s increasing focus on providing universal access to health care services will likely contribute to further growth in demand for these drugs over time.
One major driver behind the growth of the Indonesia tetracyclin market it he rise in cases od infectious disease within Indonesia itself due to poor sanitation practices along with environmental factors like climate change leading top more frequent outbreaks every year. This leads directlyo an heightened need fo rhis typef medication at both public sector level s well lkike private institutions alike. Additionally ,the aging population also drives sales up since elderly people typically require more medical attention due their decreased immunity levels coupled with higher probabilities o contracting certain types off illnesses often treated byt etrcyclins amongst other medications.
The COVID-19 pandemic has had a major impact on the Indonesia tetracyclin market, which is heavily reliant on imports from other countries. The strict quarantine and travel restrictions imposed by the government have made it difficult to obtain new supplies of the drug, leading to shortages in some areas. Furthermore, as healthcare budgets are strained due to increased costs associated with fighting COVID-19, demand for tetracyclin has decreased significantly.
The main challenge facing the Indonesia tetracyclin market is increasing price competition from generic versions of the drug coming into Indonesia from other countries. This has led to lower prices in recent years and reduced profits for manufacturers and distributors. Moreover, there have been reports of counterfeit drugs entering Indonesia supply chain as well as concerns about safety and efficacy amongst health professionals due to fake drugs being sold in pharmacies or online retailers without proper regulation or oversight.
Major players operating in the Indonesia tetracyclin market include Surya Farma Laboratories Tbk., PT Mayapada Pharmindo Lestari (MPL), PT Novell Pharmaceutical Laboratories (Novell Pharma), Kalbe Farma Tbk., Kimia Farma Tbk., Sanbe Farma Tbk., Dexa Medica Group, Dankos Laboratory Tbk., Unipharm Incorporated Ltd, GlaxoSmithKline Pte Ltd (GSK) and Pfizer Limited among others.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Tetracyclin Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Tetracyclin Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Tetracyclin Market - Industry Life Cycle |
3.4 Indonesia Tetracyclin Market - Porter's Five Forces |
3.5 Indonesia Tetracyclin Market Revenues & Volume Share, By Forms, 2021 & 2031F |
3.6 Indonesia Tetracyclin Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Indonesia Tetracyclin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Indonesia Tetracyclin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Tetracyclin Market Trends |
6 Indonesia Tetracyclin Market, By Types |
6.1 Indonesia Tetracyclin Market, By Forms |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Tetracyclin Market Revenues & Volume, By Forms, 2018 - 2031F |
6.1.3 Indonesia Tetracyclin Market Revenues & Volume, By Capsules, 2018 - 2031F |
6.1.4 Indonesia Tetracyclin Market Revenues & Volume, By Powder, 2018 - 2031F |
6.1.5 Indonesia Tetracyclin Market Revenues & Volume, By Tablets, 2018 - 2031F |
6.2 Indonesia Tetracyclin Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Tetracyclin Market Revenues & Volume, By Clomocycline, 2018 - 2031F |
6.2.3 Indonesia Tetracyclin Market Revenues & Volume, By Chlortetracycline, 2018 - 2031F |
6.2.4 Indonesia Tetracyclin Market Revenues & Volume, By Metacycline, 2018 - 2031F |
6.2.5 Indonesia Tetracyclin Market Revenues & Volume, By Lymecycline, 2018 - 2031F |
6.2.6 Indonesia Tetracyclin Market Revenues & Volume, By Meclocycline, 2018 - 2031F |
6.2.7 Indonesia Tetracyclin Market Revenues & Volume, By Chlortetracycline, 2018 - 2031F |
6.2.8 Indonesia Tetracyclin Market Revenues & Volume, By Others, 2018 - 2031F |
6.2.9 Indonesia Tetracyclin Market Revenues & Volume, By Others, 2018 - 2031F |
6.3 Indonesia Tetracyclin Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Tetracyclin Market Revenues & Volume, By Respiratory, 2018 - 2031F |
6.3.3 Indonesia Tetracyclin Market Revenues & Volume, By Bowel, 2018 - 2031F |
6.3.4 Indonesia Tetracyclin Market Revenues & Volume, By Genital, 2018 - 2031F |
6.3.5 Indonesia Tetracyclin Market Revenues & Volume, By Systemic Infections, 2018 - 2031F |
7 Indonesia Tetracyclin Market Import-Export Trade Statistics |
7.1 Indonesia Tetracyclin Market Export to Major Countries |
7.2 Indonesia Tetracyclin Market Imports from Major Countries |
8 Indonesia Tetracyclin Market Key Performance Indicators |
9 Indonesia Tetracyclin Market - Opportunity Assessment |
9.1 Indonesia Tetracyclin Market Opportunity Assessment, By Forms, 2021 & 2031F |
9.2 Indonesia Tetracyclin Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Indonesia Tetracyclin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Indonesia Tetracyclin Market - Competitive Landscape |
10.1 Indonesia Tetracyclin Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Tetracyclin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |